Molecular markers in the diagnosis and prognosis of bladder cancer.
D000017:ABO Blood-Group System / Q000235:genetics; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D002295:Carcinoma, Transitional Cell / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D004187:Disaccharides / Q000032:analysis; D004912:Erythrocytes / Q000276:immunology; D006386:Hemagglutination Tests; D006801:Humans; D007104:Immune Adherence Reaction; D007124:Immunoenzyme Techniques; D007519:Isoantigens / Q000032:analysis; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000032:analysis*; D009857:Oncogenes; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000235:genetics
D000017:ABO Blood-Group System; D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D004187:Disaccharides; D007519:Isoantigens; D009363:Neoplasm Proteins; C016467:Thomsen-Friedenreich antigen